Last reviewed · How we verify
NCT03926234
Effectiveness of a Four-level Chinese Emergency Triage Scale in Mainland China
trial testing Four-level Chinese Emergency triage scale in Emergencies in 30,687 participants. Completed in 30 December 2020.
31 December 2019
Quick facts
| Lead sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30,687 |
| Start date | 1 January 2018 |
| Primary completion | 31 December 2019 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Four-level Chinese Emergency triage scale
Conditions studied
- Emergencies — all drugs for Emergencies →
- Triage — all drugs for Triage →
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Who can join
14 and older, any sex, with Emergencies or Triage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Inter-rater reliability between experts and triage nurses was assessed in 484 emergency patients. The criterion-related validity was evaluated in other 30687 emergency patients, based on emergency department (ED) mortality, the length of stay in ED, the number of discharge, and hospitalization (intensive care/general ward).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03926234
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Emergencies
Currently open trials in the same condition.
- NCT06565390 — Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization · NA · recruiting
- NCT07051668 — The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls · NA · recruiting
- NCT06680778 — Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch · recruiting
- NCT07008391 — High-Sensitivity Troponin I in Addition to Guideline-Based Care in EMS · NA · recruiting
- NCT07027813 — Feasibility and Efficacy of Ambulance-Based m-Health for Pediatric Emergencies (FEAMER) Trial · NA · recruiting
Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials
Trials by the same sponsor.
- NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
- NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
- NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
- NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
- NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03926234 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
- Last refreshed: 18 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03926234.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing